Systemic Lupus Erythematosus Within the Framework of the Multidisciplinary Consultation
- Status
- RECRUITING
- Phase
- NA
Clinical Trials Related to Systemic Lupus Erythematosus
Related studies linked through entity extraction aliases.
A Study of ICP-022 in Patients With Systemic Lupus Erythematosus (SLE)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
- Status
- COMPLETED
- Phase
- PHASE3
Evaluation of Janus Kinase_3 in Juvenile Onset Systemic Lupus Erythematosus
- Status
- UNKNOWN
- Phase
- N/A
Immune Mediators and Metabolites to Stratify Systemic Lupus Erythematosus Patients at High Risk of Cardio Vascular Diseases
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
The Safety and Efficacy of Zishenqing in Subjects With Active Systemic Lupus Erythematosus
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata
- Status
- COMPLETED
- Phase
- N/A
Study to Assess Safety and Effectiveness of Branebrutinib Treatment in Participants With Active Systemic Lupus Erythematosus or Primary Sjögren's Syndrome, or Branebrutinib Treatment Followed by Open-label Abatacept Treatment in Study Participants With Active Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE2
Treatment of Systemic Lupus Erythematosus With Pooled Allogenic Mesenchymal Stem Cells
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Human Papilloma Virus Vaccination and Chronic Inflammatory Rheumatic Diseases.
- Status
- COMPLETED
- Phase
- N/A
Study of Subcutaneous (SC) Belimumab in Pediatric Participants With Systemic Lupus Erythematosus (SLE)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
LUPUS Brain: tACS to Target the Neurophysiology of Depression, Cognitive Deficits, and Pain in Patients With SLE
- Status
- TERMINATED
- Phase
- NA
Single Dose Study to Investigate the Pharmacokinetics (PK) and Safety of Belimumab 200 Milligrams (mg) Intravenous and 200 mg Subcutaneous Via Auto-injector in Chinese Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Haematological Indices in Systemic Lupus Erythematosus
- Status
- UNKNOWN
- Phase
- N/A
Study of Recombinant Human B Lymphocyte(RC18) Administered Subcutaneously to Subjects With Systemic Lupus Erythematosus(SLE)
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of Low-dose IL-2 in Patients With SLE: a Multicenter, Randomised, Placebo-controlled Trial
- Status
- COMPLETED
- Phase
- PHASE2
Treatment of Periodontal Disease in Systemic Lupus Erythematosus
- Status
- UNKNOWN
- Phase
- NA
Predictors of Mortality in Patients With Autoimmune Diseases Admitted to the Intensive Care Unit
- Status
- UNKNOWN
- Phase
- N/A
Ramipril, Endothelial Function and Endothelial Progenitor Cells in Patients With Systemic Lupus Erythematosus
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Effect of Curcumin on Systemic Lupus Erythematosus
- Status
- TERMINATED
- Phase
- PHASE2